Aldosterone testing: evaluation of a novel automated immunoassay

Aldosterone levels are increased in primary aldosteronism (PA) and might be triggered in several cardiovascular disorders. The aim of our study was to assess the analytical validity of a novel automated aldosterone immunoassay. Method comparison was also performed with a reference radioimmunoassay. We report for the first time the analytical validity of the LIAISON® aldosterone automated immunoassay. Such automated assay might therefore facilitate the screening of PA and risk stratification of cardiovascular diseases.